Article
22q11 Gene dosage establishes an adaptive range for sonic hedgehog and retinoic acid signaling during early development.
Human molecular genetics - 15 Jan 2013
Maynard Thomas M, Gopalakrishna Deepak, Meechan Daniel W, Paronett Elizabeth M, Newbern Jason M, LaMantia Anthony-Samuel
Abstract excerpt
We asked whether key morphogenetic signaling pathways interact with 22q11 gene dosage to modulate the severity of cranial or cardiac anomalies in DiGeorge/22q1 deletion syndrome (22q11DS). Sonic hedgehog (Shh) and retinoic acid (RA) signaling is altered in the brain and heart-clinically significant 22q11DS phenotypic sites-in LgDel mouse embryos, an established 22q11DS model. LgDel embryos treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
